The impact of semaglutide on wound healing in diabetes related foot ulcer patients: A TriNetX database study

被引:0
|
作者
Lewis, Joshua E. [1 ]
Omenge, Diana K. [2 ]
Patterson, Amani R. [1 ]
Anwaegbu, Ogechukwu [1 ]
Tabukum, Nangah N. [1 ]
Lewis III, Jimmie E. [3 ]
Lee, Wei-Chen [4 ]
机构
[1] Univ Texas Med Branch, John Sealy Sch Med, Galveston, TX USA
[2] Univ Houston, Tilman J Fertitta Coll Med, Sch Med, Houston, TX USA
[3] Barry Univ, Sch Podiatr Med, Miami, FL USA
[4] Univ Texas Med Branch, Dept Family Med, 301 Univ Blvd, Galveston, TX 77555 USA
来源
DIABETES & VASCULAR DISEASE RESEARCH | 2025年 / 22卷 / 02期
关键词
Diabetes related foot ulcers; semaglutide; GLP-1 receptor agonists; wound healing; diabetes complications; CHALLENGES;
D O I
10.1177/14791641251322909
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Diabetes related foot ulcers (DFUs) are common complications of type 2 diabetes mellitus (T2DM), affecting 15-25% of individuals living with diabetes and significantly contributing to healthcare costs ($9-13 billion annually in the U.S.). Without effective management, these wounds often lead to severe outcomes like amputations. This study aims to examine the association of semaglutide on DFU management. Methods: This retrospective cohort study utilized TriNetX US Research Network data to assess the impact of semaglutide, a GLP-1 receptor agonist, on DFU outcomes between 2013 and 2023. The study compared outcomes between semaglutide users with DFU (Cohort A, N = 6329) and non-users with DFU (Cohort B, N = 118,821) across 64 healthcare organizations. We matched participants by age, gender, race, and ethnicity; however, we excluded patients with certain co-morbidities. Statistical analysis, such as chi-square analysis and risk ratio, using TriNetX software evaluated different complication outcomes. Results: Semaglutide users with DFU demonstrated lower relative risks for complications compared to non-users. Within 1 year, semaglutide users were associated with lower relative risks for wound healing complications (0.19% vs 0.38%), chronic non-healing wounds (0.75% vs 1.23%), chronic pain (4.44% vs 8.06%), wound care (2.42% vs 4.86%), wound dehiscence (0.26% vs 0.56%), and amputation (2.34% vs 5.21%) (p < .05). Similar trends persisted over 5 years. While these findings highlight potential benefits of semaglutide with patients with DFU, causation cannot be inferred due to the study's observational design. Conclusion: Semaglutide use was associated with favorable outcomes in patients with diabetes-related foot ulcers, including reductions in wound-related complications. While these findings suggest potential benefits of semaglutide as an adjunct in DFU management, further research is needed to confirm these associations and to better understand the mechanisms involved.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Authors' Response to Letter to the Editor Re: The Effect of Foot Exercises on Wound Healing in Type 2 Diabetic Patients With a Foot Ulcer: A Randomized Control Study
    Eraydin, Sahizer
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2018, 45 (04) : 300 - 300
  • [32] Neighborhood socioeconomic disadvantage is not associated with wound healing in diabetic foot ulcer patients treated in a multidisciplinary setting
    Hicks, Caitlin W.
    Canner, Joseph K.
    Mathioudakis, Nestoras
    Sherman, Ronald L.
    Hines, Kathryn
    Lippincott, Christopher
    Black, James H., III
    Abularrage, Christopher J.
    JOURNAL OF SURGICAL RESEARCH, 2018, 224 : 102 - 111
  • [33] COMPARATIVE COST-EFFECTIVENESS OF BECAPLERMIN GEL ON WOUND HEALING AND AMPUTATION IN PATIENTS WITH DIABETIC FOOT ULCER
    Gilligan, A. M.
    Waycaster, C.
    VALUE IN HEALTH, 2014, 17 (03) : A248 - A249
  • [34] Comparison of the effects of cilostazol and aspirin on wound healing in patients with diabetic foot ulcer and peripheral artery disease
    Colak, Bayram
    Orhan, Atilla
    Ece, Ilhan
    Yormaz, Serdar
    Yilmaz, Huseyin
    Sahin, Mustafa
    ANNALI ITALIANI DI CHIRURGIA, 2020, 91 (02) : 225 - 232
  • [35] COMPARATIVE COST-EFFECTIVENESS OF BECAPLERMIN GEL ON WOUND HEALING IN PATIENTS WITH DIABETIC FOOT ULCER: CHANGES IN WOUND SURFACE AREA
    Waycaster, C.
    Gilligan, A. M.
    VALUE IN HEALTH, 2014, 17 (03) : A249 - A249
  • [36] Wound healing outcomes in a diabetic foot ulcer outpatient clinic at an acute care hospital: a retrospective study
    Lu, S. H.
    McLaren, A-M.
    JOURNAL OF WOUND CARE, 2017, 26 (10) : S4 - S11
  • [37] Micronutrients and Natural Compounds Status and Their Effects on Wound Healing in the Diabetic Foot Ulcer
    Kulprachakarn, Kanokwan
    Ounjaijean, Sakaewan
    Wungrath, Jukkrit
    Mani, Raj
    Rerkasem, Kittipan
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2017, 16 (04): : 244 - 250
  • [38] Preliminary investigation of topical nitroglycerin formulations containing natural wound healing agent in diabetes-induced foot ulcer
    Hotkar, Mukesh S.
    Avachat, Amelia M.
    Bhosale, Sagar S.
    Oswal, Yogesh M.
    INTERNATIONAL WOUND JOURNAL, 2015, 12 (02) : 210 - 217
  • [39] Diabetic foot ulcer photography study: a study within a trial to assess the reliability of two-dimensional (2D) photography for the assessment of ulcer healing in patients with diabetes-related foot ulcers-protocol paper
    Brown, Sarah Tess
    Collier, Howard
    Askew, Lucy
    Gilberts, Rachael Mary
    Sharples, Linda D.
    Nixon, Jane
    Mcginnis, Elizabeth
    Backhouse, Michael
    Game, Frances
    Faulks, Phil
    Ransom, Myka
    Everett, Colin Charles
    Nelson, E. Andrea
    Russell, David
    BMJ OPEN, 2025, 15 (01):
  • [40] Early Revascularization after Admittance to a Diabetic Foot Center Affects the Healing Probability of Ischemic Foot Ulcer in Patients with Diabetes
    Elgzyri, T.
    Larsson, J.
    Nyberg, P.
    Thorne, J.
    Eriksson, K. -F.
    Apelqvist, J.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2014, 48 (04) : 440 - 446